Top Markets
Coin of the day
Paion AG Paion AG

Paion AG

PA8
Classement en actions #35969
Paion AG is a specialized pharmaceutical firm engaged in the global development... Paion AG is a specialized pharmaceutical firm engaged in the global development and commercialization of medicines for hospital settings, specifically addressing needs in sedation, anesthesia, and critical care. Its primary compound, Remimazolam, is an ultra-short-acting intravenous benzodiazepine designed as a sedative/anesthetic, currently progressing through clinical trials for applications in procedural sedation, general anesthesia, and intensive care unit sedation. The company's pipeline also includes Angiotensin II, a vasoconstrictor for treating severe low blood pressure in adults experiencing septic or other forms of distributive shock, and Eravacycline, a new fluorocycline antibiotic targeting complex intra-abdominal infections in adults. Paion AG collaborates with various partners through licensing and strategic agreements, including Cosmo Pharmaceuticals, Wuhan Humanwell Innovative Drug Research and Development Center Limited Company, Hana Pharm, Yichang Humanwell, and Mundipharma. Established in 2000, Paion AG operates from Aachen, Germany.
Prix de l'action
$0.42701586
Dernière synchronisation: 2023-11-01
Capitalisation boursière
$3.21M
Changement (1 jour)
16.99%
Changement (1 an)
0.00%
Pays
DE
Échange Paion AG (PA8)

Catégorie

Historique du prix de l'action pour Paion AG (PA8)
Prix de clôture le plus élevé : $0.43 le 2023-11-01

Prix de clôture le plus bas : $9.35 le 2022-11-01
Historique du prix de l'action de Paion AG de 2022 à 2026
Performance annuelle du prix de l'action
Année Performance
2023 -93.62%
2022 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$161.67 23.26%
DE
$36.61 22.16%
JP
$225.00 37.51%
CH
$21.30 13.79%
IN